Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
EDG-7500 Phase 2 Results Expected
EDG-7500 • Hypertrophic Cardiomyopathy
Target Indication
Hypertrophic Cardiomyopathy
Clinical Trial
Last updated: 12/4/2025
EWTX
Edgewise Therapeutics, Inc.
Duchenne Muscular Dystrophy
Becker Muscular Dystrophy